The idiopathic thrombocytopenic purpura (ITP) therapeutics market involves treatments designed to manage and treat ITP, a rare autoimmune disorder that leads to abnormally low platelet counts, increasing the risk of bleeding and bruising. The market encompasses various therapeutic approaches, including corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and other immun... https://linkewire.com/2024/10/15/idiopathic-thrombocytopenic-purpura-therapeutics-market-novel-approaches-to-blood-disorder-management-up-to-2033/